Results 11 to 20 of about 5,643,282 (147)

National survey of the prevalence, incidence, primary care burden, and treatment of heart failure in Scotland [PDF]

open access: yes, 2004
Objective: To examine the epidemiology, primary care burden, and treatment of heart failure in Scotland, UK. Design: Cross sectional data from primary care practices participating in the Scottish continuous morbidity recording scheme between 1 April ...
Chalmers, J.   +9 more
core   +8 more sources

Introduction of Blood Volume Analysis to Guide Ambulatory Advanced Heart Failure Care

open access: yes, 2023
Poster presented at the HFSA Annual Scientific Meeting, 2023.Introduction: The current landscape for patients referred to Advanced Heart Failure Clinics is dominated by patients with recent admissions for decompensated heart failure, advanced functional
Silver, Marc A.   +3 more
core   +5 more sources

Advanced chronic heart failure: A position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Societyof Cardiology [PDF]

open access: yes, 2007
Therapy has improved the survival of heart failure (HF) patients. However, many patients progress to advanced chronic HF (ACHF). We propose a practical clinical definition and describe the characteristics of this condition.
METRA, Marco   +1 more
core   +3 more sources

Heart Failure Statistics in Korea, 2020: A Report from the Korean Society of Heart Failure [PDF]

open access: yes, 2021
Background and Objectives Heart failure (HF) is a disease with high morbidity and mortality. With ageing society and increasing prevalence of risk factors of HF, the prevalence of HF is expected to increase, as well. In this official report of the Korean
이찬주   +28 more
core   +1 more source

From Hip to Heart: A Comprehensive Evaluation of an Infiltrative CardiomyopathyNovel Teaching Points

open access: yesCJC Open, 2021
Infiltrative cardiomyopathies are an increasingly recognized cause of heart failure warranting systematic evaluation. Given overlap of clinical and imaging findings among etiologies of infiltrative cardiomyopathies, comprehensive evaluation, including a ...
Manavotam Singh, MD   +9 more
doaj   +1 more source

Oral milrinone for management of refractory right ventricular failure in patients with left ventricular assist devices

open access: yesESC Heart Failure, 2022
Aims We present a single‐centre retrospective experience using oral milrinone in patients with a left ventricular assist device (LVAD) and concurrent refractory right ventricular failure.
Waqas Akhtar   +7 more
doaj   +1 more source

Natriuretic peptide biomarkers in the imminent development of preeclampsia

open access: yesFrontiers in Cardiovascular Medicine, 2023
Preeclampsia is the most common cause of morbidity and mortality in pregnancy, the incidence being significantly higher in low-income countries with reduced access to health care.
Stefanie Marek-Iannucci   +5 more
doaj   +1 more source

Advances in diastolic heart failure

open access: yesWorld Journal of Cardiology, 2010
More than 50% of people living with congestive heart failure have diastolic heart failure (DHF). Most of them are older than 70 years, and female. The prevalence of DHF has increased with time. DHF is caused by left ventricular (LV) diastolic dysfunction (DD) which is induced by diastolic dyssynchrony.
Xing Sheng, Yang, Jing Ping, Sun
openaire   +2 more sources

Advances in Heart Failure

open access: yesCurrent Pharmaceutical Design, 2023

Deftereos, S.   +2 more
openaire   +2 more sources

Transendocardial CD34+ Cell Therapy does not Increase the Risk of Ventricular Arrhythmias in Patients with Chronic Heart Failure

open access: yesCell Transplantation, 2019
Ventricular arrhythmias (VA) are of major concern in the field of cell therapy, potentially limiting its safety and efficacy. We sought to investigate the effects of CD34 + cell therapy on VA burden in patients with chronic heart failure (CHF).
Gregor Poglajen   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy